Margin Crash, Core Stall, Revival Hinges on a Price Hike That Hasn't Happened
Revenue grew 5.7% but profit fell 9.5% — a 620-basis-point miss against prior 11–12% PAT margin guidance. Management blames wage inflation and lack of pricing power. Recovery depends entirely on an IBA price revision that remains unconfirmed.
₹5.2 Cr
4.8% margin
~₹11.6 Cr
11–12% margin implied
₹6.4 Cr
620 bps margin miss
On the top line, Radiant delivered a respectable quarter: ₹105.7 crore in revenue, up 5.7% year-on-year, with cash volume handled rising 2.3% to ₹0.43 trillion. But profit tells a different story. Net PAT of ₹5.2 crore fell 9.5% despite revenue growth, a disconnect that exposes a structural margin compression the company has yet to fix.
The margin collapse: where it came from
Standalone EBITDA margin compressed 240 basis points year-on-year, to 13.5% from 15.9%. Management attributes this to two structural headwinds: wage inflation among gunmen (acute shortage in southern states driving up costs) and minimum-wage hikes in northern states and Karnataka. These are not one-time costs. They're ongoing.
The consolidated EBITDA margin of 11.01% is marginally up from the prior quarter's 10.7%, but it sits well below the company's stated FY27 target of 17–18%. To reach that, management is banking on a price revision — an increase to cash management fees negotiated through the Indian Bank Association (IBA). The IBA committee is expected to decide in Q2 FY27 (current quarter), with an effective date of July, September, or October. Pending.
The company has sought significant price revision with all its customers and expects the same to materialize in the current quarter.
Where growth actually sits
The headline 5.7% revenue growth masks a stalled core business. Stripping out the new IDBI Bank mandate (~₹4 crore per quarter) and the Radiant Valuable Logistics (RVL) subsidiary (~₹2.2 crore quarterly), core cash management revenue grew only 3–4% year-on-year, roughly half the inflation rate. This is the real problem.
Management is addressing this by shifting the revenue mix toward direct clients (corporates, retail networks) rather than relying on banks for points. Direct clients now represent 18.4% of cash management revenue, up 410 basis points year-on-year from 14.3%. This is strategically sound — higher margins, less dependence on bank volume — but the absolute growth is slow. Banks are reducing points as digital payments eat into cash handling volumes and competitive pressure intensifies.
7% standalone revenue growth driven by IDBI mandate
Consolidated growth 5.7%; IDBI contributed ~₹4 Cr; core ex-IDBI ~3–4%, below inflation
Overstated
Cash losses ₹2M — industry-best risk management
₹2.06M reported, exact match; best since IPO 2023
Supported
Direct clients 18.4%, up from 14.3% — positive mix shift
Exact match; +410bps mix expansion, but absolute growth still weak (3–4% ex-IDBI)
Supported (caveat: scale slow)
EBITDA margins to recover to 17–18% FY27
Q1 standalone EBITDA 13.5%; recovery contingent on unconfirmed price revision from IBA
Contingent
Acemoney to reach EBITDA breakeven in current quarter (Q2)
Revised to September (Q3); transaction revenue only ₹70 lakhs Q1; employee costs ₹8–10 Cr annually
Contradicted (timeline slipped)
What changed on this call
EBITDA margin compression YoY (240bps). Wage inflation blamed; recovery via unconfirmed price revision.
Acemoney breakeven slipped from H1 FY27 to September (Q3). PIDF subsidy discontinued; organic ramp slower than expected.
Core revenue growth (ex-deals) revealed as 3–4%, below inflation. Shift to direct clients now central strategy, not supporting upside.
Price revision elevated as primary margin recovery lever. Now explicit; was implicit in prior guidance. Represents shift from growth-led to pricing-led margin fix.
How the street is positioned
The stock announced results on Wed Aug 12 and the market reaction was swift and unforgiving. The day-1 decline of 2.91% accelerated to −8.19% by day 3 and −10.48% by day 5 — and the losses held. This is not a snap overreaction that faded into a bounce; it's a repricing that the market considers justified.
At ₹35.75 (as of Aug 24), the stock trades 35% below its all-time high and sits below its 20-day, 50-day, and 200-day simple moving averages — a textbook bearish setup. The stock has rallied 10.58% from its 52-week low but that recovery is trapped in a downtrend. RSI of 39.1 signals neutral momentum, not oversold.
Institutional flows are also telling. FII ownership dropped 9 basis points quarter-on-quarter (to 0.21% in Q1 FY27 from 0.30% in Q4 FY26), while domestic institutional holding barely moved. There is no sign of conviction buying into the pullback. The bulk deal activity (a Motilal Oswal sell/buy of ₹2 crore at ₹35.33 in March) was routine liquidity, not a conviction bet or insider signal.
The fundamental read aligns with the price action: missed guidance, stalled core growth, and a margin recovery thesis that hinges on external approval. The market is rationally waiting for proof.
The bull-bear ledger
21-year track record in a mission-critical niche (cash logistics). Difficult to replicate.
Lowest cash losses in the industry (₹2.06M on ₹0.43 Tr). Risk management expertise is genuine.
FY28 guidance quantified: 12–13% revenue growth, 19–20% consolidated EBITDA. Concrete targets.
Direct client channel emerging (18.4% mix). Higher margins, less bank dependence. Strategic pivot sound.
PAT fell 9.5% despite 5.7% revenue growth. Margin collapse is real and ongoing.
Core growth (ex-IDBI, ex-RVL) is 3–4% — below inflation. Structural headwind.
Price revision is external dependency. No control; pending IBA decision with no quantum disclosed and timing uncertain (July vs. Sept vs. Oct).
Wage inflation (gunmen shortage, min-wage hikes) is structural, not one-time. Unresolved absent price power.
Acemoney profitability slipped H1 → Q3. ₹30 Cr lost to payments banks unrecovered; nascent Soundbox deployment at ₹70 lakh quarterly revenue.
Customer concentration: 42 banks, only 3–4 pan-India competitors. Loss of one large mandate material.
Risks, ranked by severity for a holder
Price revision does not materialize or is delayed beyond Q2
HighEntire FY27 margin recovery target (17–18% EBITDA) depends on IBA approval and effective implementation. If this slips or dies, EBITDA margins stay compressed at 13–14%, and FY27 guidance must be cut.
Core cash management revenue growth remains flat (3–4%) as digital payments and payment banks erode volumes
HighStructural headwind, not cyclical. Even with price revision and direct client expansion, top-line growth could prove insufficient to sustain profitability growth targets. Long-term TAM contraction risk.
Wage inflation proves ongoing and unresolved absent price hikes
MediumThe 240bps EBITDA margin compression YoY is attributed to gunman cost inflation and min-wage hikes. These are recurrent costs. If price revision fails or is insufficient, margins compress further.
Acemoney profitability timeline slips further; business case questioned
MediumH1 breakeven target already missed (now Q3). Annual employee costs of ₹8–10 Cr vs. ₹70 lakh quarterly revenue imply uncertain path to meaningful contribution. Analysts questioned strategic rationale; risk of writedown.
Loss of material bank customer (IDBI or another anchor mandate)
MediumOnly 3–4 pan-India operators serve 42 banks. Losing a large mandate (e.g., IDBI at ₹4 Cr/Qtr) would be material to results. Competitive intensity from pricing or service expectations could shift.
RVL fails to scale beyond ₹20–30 Cr annualized; remains boutique business
LowAt ₹22.1 Cr Q1 (₹88 Cr annualized run-rate), RVL is ~5% of consolidated revenue and was expected to be a meaningful growth driver. If momentum stalls, consolidated growth target at risk.
What management got wrong (and what to watch next)
On the earnings call, Q&A was pointed. Analyst Vinit Sahu pressed hard on why core growth of 3–4% was so weak (below inflation) when wage cost inflation had been evident since March—why wait 5 months for a price revision? C. Jagannathan questioned Acemoney's strategic value with minimal revenue and ₹8–10 Cr in costs. Ankit Kanodia sought buyback signals, hinting the market lacks confidence. Management was transparent but defensive; management acknowledged challenges but repeatedly cited externals (IBA timing, market conditions) beyond its control.
1 · Q2 FY27 (September 2026): IBA price revision decision
The most material near-term catalyst. Announcement and quantum of price hike will confirm or refute the 17–18% EBITDA guidance. Effective date (July, September, or October) matters for Q2/Q3 quantum.
2 · Q3 FY27 (December 2026): Acemoney EBITDA breakeven and RVL full-quarter profitability
Execution proof on subsidiary timeline. Any further slippage signals execution risk. Acemoney revenue contribution relative to cost base will clarify strategic value.
3 · Jan–Feb FY28: RBI payment aggregator license approval
Revised application expected to be filed end Aug / early Sep (per call). RBI approval ~4–5 months later. License unlocks digital banking ecosystem for Acemoney; material upside if approved but far-term catalyst.
The honest read
The number to track from here is core revenue growth ex-deals: it needs to accelerate from the current 3–4% toward low double digits, price revision or not. That would signal that the direct client shift is gaining traction and that structural digitization headwinds are being offset by strategy. Until then, the margin miss and guidance cut are not behind you; they are the preview of where execution stands.
Informational and educational content only. Not investment advice.